GGrantIndex
← Search

Interdisciplinary training in pharmacological sciences

$213,180T32FY2025GMNIH

Brown University, Providence RI

Investigators

Linked publications, trials & patents

Abstract

Enter the text here that is the new abstract information for your application. This section must be no longer than 30 lines of text. The Graduate Program in Molecular Pharmacology & Physiology is a small  program with a strong set of courses and activities, as well as extensive mentoring mechanisms.  Leadership of the program is by a group of three accomplished MPIs with complementary strengths and expertise that guarantee effective oversight of the program. The request is for 4  T32 slots per year; the total number of students in the program is 20. This training program in  "Interdisciplinary Training in Pharmacological Sciences" will replace our current NIGMS  pharmacology T32, ending in June of 2021. The training in our program focuses on fundamental  principles of pharmacology, rigor and reproducibility, and cutting-edge quantitative methods. Our  trainees participate in many activities that promote interaction, collaboration and professional  development. Here we propose a number of new initiatives in the curriculum, professional  development, program oversight and recruitment. A recent innovative initiative we are developing in the program is the establishment of summer internships at Pfizer pharmaceutical company  labs; these internships will give our trainees the unique opportunity to experience first-hand the  scientific environment in a pharmaceutical company and make informed decisions for their future  careers. Our current admissions and recruitment practices have yielded a group of students with broad interests in the field and retention for the program overall is 95% over the last 15 years.  The career outcomes of the students are excellent, with 52% of students staying in academia  (25% faculty, 27% currently postdocs) often at top institutions, about 25% as scientists in  pharmaceutical or biotechnology companies, and the remainder in a variety of science and  medicine-related careers. Thus, our program has been training a group of students with broad interests in the field who have become successful in different areas of science; the new initiatives proposed in our  T32 application will further enhance our unique program and improve the quality of the training.Â

View original record on NIH RePORTER →